CRDL vs. LAC
CRDL (Cardiol Therapeutics Inc Class A) and LAC (Lithium Americas Corp.) are both stocks. CRDL operates in Drug Manufacturers - Specialty & Generic (Healthcare), while LAC operates in Other Industrial Metals & Mining (Basic Materials). Over the past year, CRDL returned -17.83% vs 10.18% for LAC. At a 0.18 correlation, their price movements are largely independent.
Performance
CRDL vs. LAC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRDL achieves a 11.13% return, which is significantly higher than LAC's -27.98% return.
CRDL
- 1D
- 4.95%
- 1M
- 2.91%
- 6M
- 10.42%
- YTD
- 11.13%
- 1Y
- -17.83%
- 3Y*
- 9.21%
- 5Y*
- -14.79%
- 10Y*
- —
LAC
- 1D
- -5.42%
- 1M
- -30.99%
- 6M
- -45.49%
- YTD
- -27.98%
- 1Y
- 10.18%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CRDL vs. LAC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
CRDL Cardiol Therapeutics Inc Class A | 11.13% | -25.48% | 51.80% | -5.79% |
LAC Lithium Americas Corp. | -27.98% | 46.80% | -53.59% | -27.19% |
Correlation
The correlation between CRDL and LAC is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Oct 2, 2023 | 0.18 |
Fundamentals
CRDL:
$122.19M
LAC:
$701.09M
CRDL:
-CA$0.37
LAC:
-$0.26
CRDL:
8.41
LAC:
0.82
CRDL:
CA$0.00
LAC:
$0.00
CRDL:
-CA$25.95K
LAC:
-$580.22K
CRDL:
-CA$34.00M
LAC:
-$52.10M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRDL vs. LAC — Risk / Return Rank
CRDL
LAC
CRDL vs. LAC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cardiol Therapeutics Inc Class A (CRDL) and Lithium Americas Corp. (LAC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRDL | LAC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.35 | ||
| Sortino ratioReturn per unit of downside risk | -1.32 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 1.15 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | -0.45 | 0.15 | -0.60 |
| Martin ratioReturn relative to average drawdown | -0.62 | 0.23 | -0.85 |
Loading charts...
Drawdowns
CRDL vs. LAC - Drawdown Comparison
The maximum CRDL drawdown since its inception was -92.71%, which is greater than LAC's maximum drawdown of -81.83%. Use the drawdown chart below to compare losses from any high point for CRDL and LAC.
Loading charts...
Drawdown Indicators
| CRDL | LAC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.71% | -81.83% | -10.88% |
Max Drawdown (1Y)Largest decline over 1 year | -39.48% | -68.76% | +29.28% |
Max Drawdown (3Y)Largest decline over 3 years | -72.73% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -90.72% | — | — |
Current DrawdownCurrent decline from peak | -82.88% | -73.21% | -9.67% |
Average DrawdownAverage peak-to-trough decline | -69.13% | -63.23% | -5.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.77% | 44.75% | -15.98% |
Volatility
CRDL vs. LAC - Volatility Comparison
The current volatility for Cardiol Therapeutics Inc Class A (CRDL) is 10.42%, while Lithium Americas Corp. (LAC) has a volatility of 14.17%. This indicates that CRDL experiences smaller price fluctuations and is considered to be less risky than LAC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRDL | LAC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.42% | 14.17% | -3.75% |
Volatility (6M)Calculated over the trailing 6-month period | 40.53% | 51.76% | -11.23% |
Volatility (1Y)Calculated over the trailing 1-year period | 66.84% | 132.41% | -65.57% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 86.95% | 100.47% | -13.52% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 86.55% | 100.47% | -13.92% |
Dividends
CRDL vs. LAC - Dividend Comparison
Neither CRDL nor LAC has paid dividends to shareholders.
Financials
CRDL vs. LAC - Financials Comparison
This section allows you to compare key financial metrics between Cardiol Therapeutics Inc Class A and Lithium Americas Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CRDL and LAC have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LAC has higher volatility (14.17%) compared to CRDL (10.42%). In terms of maximum drawdown, CRDL dropped -92.71% vs LAC's -81.83%.
LAC currently has the higher Sharpe Ratio (0.08 vs -0.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRDL and LAC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer